Management of women with cervicitis.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 17342663)

Published in Clin Infect Dis on April 01, 2007

Authors

Jeanne M Marrazzo1, David H Martin

Author Affiliations

1: Department of Medicine, University of Washington, Seattle, WA 98104, USA. jmm2@u.washington.edu

Articles by these authors

Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis (2005) 2.70

Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis (2004) 2.67

A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis (2009) 2.64

Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis (2005) 2.40

Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis (2009) 2.30

A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis (2002) 2.29

Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol (2003) 2.24

The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19

Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis (2005) 2.18

Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis (2002) 2.09

Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One (2011) 2.06

Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06

Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J Bacteriol (2004) 1.94

Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol (2006) 1.89

Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilis. Clin Infect Dis (2011) 1.88

Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol (2002) 1.85

The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation. Sex Transm Dis (2004) 1.85

Measuring sex partner concurrency: it's what's missing that counts. Sex Transm Dis (2007) 1.73

Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol (2010) 1.69

An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun (2004) 1.69

Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States. Sex Transm Dis (2009) 1.68

Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59

From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis (2008) 1.58

Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis (2003) 1.56

Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis (2002) 1.49

Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis (2005) 1.46

Clinical evaluation of the BD ProbeTec™ Chlamydia trachomatis Qx amplified DNA assay on the BD Viper™ system with XTR™ technology. Sex Transm Dis (2011) 1.33

Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis (2008) 1.31

Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome. Mol Microbiol (2007) 1.30

Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol (2008) 1.29

When and where do youths have sex? The potential role of adult supervision. Pediatrics (2002) 1.27

Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis. J Clin Microbiol (2004) 1.26

Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells. Infect Immun (2008) 1.22

Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials. Obstet Gynecol (2011) 1.21

A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol (2008) 1.20

Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections. J Clin Microbiol (2005) 1.17

Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Microbes Infect (2006) 1.15

Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol (2008) 1.14

Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J Infect Dis (2010) 1.12

Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J Clin Microbiol (2011) 1.09

A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr (2010) 1.07

Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis (2005) 1.05

Sexually transmitted infections and risk behaviors among African American women who have sex with women: does sex with men make a difference? Sex Transm Dis (2011) 1.05

Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men. Sex Transm Dis (2009) 1.04

Single-nucleotide polymorphisms in the rRNA operon and variable numbers of tandem repeats in the lipoprotein gene among Mycoplasma genitalium strains from clinical specimens. J Clin Microbiol (2004) 1.04

Genetic variation in the complete MgPa operon and its repetitive chromosomal elements in clinical strains of Mycoplasma genitalium. PLoS One (2010) 1.03

Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis (2012) 1.02

Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun (2012) 1.02

Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women. Sex Transm Dis (2010) 1.00

Chlamydia and gonorrhea co-occurrence in a high school population. Sex Transm Dis (2004) 0.95

Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis (2011) 0.94

Introduction: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control. J Infect Dis (2010) 0.93

Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin. Clin Infect Dis (2012) 0.91

Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs. Int J STD AIDS (2003) 0.89

Risk behaviours by type of concurrency among young people in three STI clinics in the United States. Sex Health (2012) 0.86

Clinical evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper™ system with XTR™ technology. Sex Transm Dis (2012) 0.85

The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin. BMC Immunol (2012) 0.84

Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model. J Infect Dis (2013) 0.84

Serum LDH level as a clue to the diagnosis of histoplasmosis. AIDS Read (2002) 0.84

Extensive variation and rapid shift of the MG192 sequence in Mycoplasma genitalium strains from patients with chronic infection. Infect Immun (2014) 0.82

The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention. Sex Transm Dis (2003) 0.82

Missed opportunities for early detection of chlamydia and gonorrhea in school-based health centers. Sex Transm Dis (2006) 0.82

Comparison of methylene blue/gentian violet stain to Gram's stain for the rapid diagnosis of gonococcal urethritis in men. Sex Transm Dis (2011) 0.82

Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis. PLoS One (2013) 0.81

Rapid plasma reagin titer variation in the 2 weeks after syphilis therapy. Sex Transm Dis (2012) 0.80

Variability of trinucleotide tandem repeats in the MgPa operon and its repetitive chromosomal elements in Mycoplasma genitalium. J Med Microbiol (2011) 0.80

The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques. AIDS Res Hum Retroviruses (2014) 0.80

Genetic diversity of Trichomonas vaginalis reinfection in HIV-positive women. Sex Transm Infect (2013) 0.79

Streptococcus pneumoniae soft tissue infections in human immunodeficiency virus. Am J Med Sci (2011) 0.79

"Testing-only" visits: an assessment of missed diagnoses in clients attending sexually transmitted disease clinics. Sex Transm Dis (2013) 0.78

Chlamydia positivity in New Orleans public high schools, 1996-2005: implications for clinical and public health practices. Acad Pediatr (2013) 0.78

Patient preference for patient-delivered partner therapy: exploratory findings from three sexually transmitted disease clinics. Sex Transm Dis (2011) 0.78

Screening methods for Chlamydia trachomatis and Neisseria gonorrhoeae infections in sexually transmitted infection clinics: what do patients prefer? Sex Transm Infect (2010) 0.77

Draft genome sequences of four axenic Mycoplasma genitalium strains isolated from Denmark, Japan, and Australia. J Bacteriol (2012) 0.77

Azithromycin Treatment Failure for Chlamydia trachomatis Among Heterosexual Men With Nongonococcal Urethritis. Sex Transm Dis (2016) 0.76

Does Antiretroviral Therapy Interfere With the Treatment of Trichomonas vaginalis Among HIV+ Women? Sex Transm Dis (2013) 0.76

The crab hole mosquito blues. Emerg Infect Dis (2011) 0.75

Rate of Decline in Nontreponemal Antibody Titers and Seroreversion After Treatment of Early Syphilis. Sex Transm Dis (2017) 0.75

Vitamin D deficiency in HIV-infected and -uninfected women in the United States. J Acquir Immune Defic Syndr (2012) 0.75

Clinical case of the month. A 63-year-old woman with lumbago. Eikenella corrodens. J La State Med Soc (2014) 0.75

A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women. Sex Transm Dis (2022) 0.75

Gonorrhea positivity in New Orleans public high schools, 1996 to 2005. Sex Transm Dis (2013) 0.75